Aether Industries Limited — Investor Meet, 08-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Aether Industries reported FY ’25 revenue growth of 38% to Rs. 880 Cr, EBITDA up 72% to Rs. 271 Cr (31% margin), and PAT nearly doubled to Rs. 158 Cr (18% margin). CRAMS and Contract/Exclusive Manufacturing now account for ~50% of revenue, targeting 70% driven by 50+ ongoing projects beyond pharma and agro. Production ramp-up continues across multiple sites, with Site-4 commercial and Site-5 commissioning by Dec 2025. Working capital cycles improved from 195 to a planned ~150 days. R&D spends steady at 6-8% of revenue with capacity doubling underway. Management focuses on strategic partnerships across sectors and innovation-driven cost efficiency, expecting EBITDA margins near 29-30% in FY ’26. Promoter holding remains above 80%, with a confident outlook on volume growth, margin stability, and contract manufacturing expansion.